Author

I. Biswas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Organism:rat· 2 Assay:whole-genome sequencing· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. T. S· 5 shared S. S. Kuduvalli· 4 shared A. Kirubananthan· 2 shared B. Veeraraghavan· 2 shared D. P. S· 2 shared D. S. Precilla· 2 shared J. J. Jacob· 2 shared K. Vasudevan· 2 shared

Activity by Year

2021-2024 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

A. T. S

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

The synergistic anti-Warburg efficacy of temozolomide, metformin and epigallocatechin gallate in glioblastoma

S. S. Kuduvalli, D. S. Precilla, I. Biswas, A. T. S

This study evaluates the anti-Warburg efficacy of temozolomide, metformin, and epigallocatechin gallate in glioblastoma models, showing reduced glucose uptake and reversed Warburg effect.

Toxicology and Applied Pharmacology · Dec 1, 2024Peer-reviewedCancer Biology

Evaluating the Anti-tumor efficacy and safety of AEV01 in Glioma and Hepatocellular Carcinoma: An In Vitro and In Vivo approach.

I. Biswas, D. Precilla, A. Kumar, S. MM, R. Medasani, A. T. S

This study evaluates the anti-tumor efficacy and safety of AEV01 in glioma and hepatocellular carcinoma using in vitro and in vivo models, finding dose-dependent cytotoxicity and reduced tumor markers with no significant organ toxicity.

bioRxiv · Jul 22, 2024 · PreprintCancer Biology

Dynamics of repurposing synthetic and natural compounds against WNT/β-Catenin signaling in glioma- An in vivo approach

D. P. S, S. S. Kuduvalli, I. Biswas, B. K, A. K. B, J. M. Thomas, A. T. S

This study evaluates a quadruple-drug combination targeting WNT/β-catenin signaling in glioma using an in vivo xenograft model, showing reduced proliferation and increased apoptosis.

bioRxiv · Dec 2, 2022 · PreprintCancer Biology

Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide-an in vitro and in silico experimental study

I. Biswas, D. S. Precilla, S. S. Kuduvalli, M. A. Ramachandran, A. S, V. Raman, D. Prabhu, A. T. S

This study evaluates the synergistic anti-glioma effects of Fucoidan with Temozolomide in vitro and in silico, showing reduced cell viability, migration, and inflammation with increased apoptosis.

bioRxiv · Dec 2, 2022 · PreprintCancer Biology

A combination of Metformin and Epigallocatechin Gallate Potentiates Glioma Chemotherapy in vivo

S. S. Kuduvalli, D. P. S, A. Vaithy, M. Purushothaman, A. R. Muralidharan, A. Kumar B, M. Mezger, J. S. Antony, M. Subramani, B. Dubashi, I. Biswas, G. K P, A. T. S

This study shows that combining metformin, epigallocatechin gallate, and temozolomide improves glioma treatment in rats by inhibiting tumor growth and increasing survival.

bioRxiv · Nov 16, 2022 · PreprintCancer Biology

Genomic rearrangements of mobile genetic elements associated with carbapenem resistance of Acinetobacter baumannii

S. Vijayakumar, J. J. Jacob, K. Vasudevan, P. Mathur, P. Ray, A. R. Neeravi, A. Baskaran, A. Kirubananthan, S. Anandan, I. Biswas, K. Walia, B. Veeraraghavan

This study characterizes genomic features of carbapenem-resistant Acinetobacter baumannii isolates from India, identifying resistance genes, mobile genetic elements, and clonal lineages.

bioRxiv · Feb 3, 2022 · PreprintMicrobiology

Colistin resistance in Acinetobacter baumannii is driven by multiple genomic traits: Evaluating the role of ISAba1-driven eptA overexpression among Indian isolates

S. Vijayakumar, J. J. Jacob, K. Vasudevan, B. A. Shankar, M. L. Francis, A. Kirubananthan, S. Anandan, K. Gunasekaran, K. Walia, I. Biswas, K. S. Kaye, B. Veeraraghavan

This study identifies ISAba1-driven eptA overexpression as a key mechanism of colistin resistance in Indian Acinetobacter baumannii isolates.

bioRxiv · Jan 7, 2021 · PreprintMicrobiology